Why I Walked Away From Star Wars--And A Good Job

Opinion Why I Walked Away From Star Wars--And A Good Job AUTHOR: RICHARD RUQUIST Date: May 16, 1988 Years before the term Strategic Defense Initiative had been coined, no one was more enthusiastic about a defensive missile shield than Richard Ruquist. The questions seemed purely technical back then, and Ruquist was an engineering bloodhound on a hot trail. But after scores of analyses, the scientist concluded that it was a terrible mistake—that a defensive system in space would be vulne

Written byRichard Ruquist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Opinion

On February 28, 1987, I resigned from-a major Strategic Defense Initiative contractor in-order to be free to publicly criticize SDI. It was a decision which has profoundly affected me, my family, and my career. I believe it was also an unusual decision; while I am not the first to criticize SDI policy, I may be the first to leave the defense establishment in order to do so.

The story begins, in 1966. New Ph.D. from Harvard in hand he began working on ballistic missile de fense systems at MIT’s Lincoln Laboratory. Nearly two decades before Ronald Reagan made such work controversial, scientists like myself could count on secure funding. But I also sincerely believed our efforts might be of crucial importance in controlling the nuclear arms race. Many of us thought that a defensive shield could make nuclear warheads obsolete, although none of us knew. whether it was technically ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies